Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation
NCT ID: NCT03896243
Last Updated: 2019-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2018-01-01
2019-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.
Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Control Group:
Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.
Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uterine artery ligation (UAL)
We would like toinvite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.
They would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Uterine artery ligation (UAL)
Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.
They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Control Group:
We would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.
They would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Uterine artery ligation (UAL)
Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.
They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uterine artery ligation (UAL)
Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.
They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no systemic or endocrine diseases
* patients who had uterine artery ligation due to atony
* healthy postpartum patients as controls
Exclusion Criteria
* Pregnancy with IVF or oosit donation
* Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
* Patients with BMI \>40
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pınar Yalcin bahat
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
uterinarter
Identifier Type: -
Identifier Source: org_study_id